Literature DB >> 26061105

Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents.

Marcos Couto1, Stefani de Ovalle1, Mauricio Cabrera1, Hugo Cerecetto1, Mercedes González1.   

Abstract

BACKGROUND: Cancer chemoprevention involves the carcinogenic process prevention, delay or reverse by the administration of chemopreventive agents, which are able to suppress or block the carcinogen metabolic activation/formation. The increased activity of phase II detoxification enzymes such as quinone-reductase (QR) and glutation-S-transferase (GST) correlates with the protection against chemically-induced carcinogenesis. It has been shown that synthetic chalcones and 3H-[1,2]-dithiole-3-thiones promote expression of genes involved in chemoprevention. MATERIALS &
METHODS: Herein, the induction of phase II enzymes by designed Michael acceptor-dithiolethione hybrids was studied. RESULTS & DISCUSSION: Hybrids 5 and 7 displayed the induction of quinone-reductase and glutation-S-transferase in vitro in the same order on the wild-type mouse-hepatoma Hepa 1c1c7 and on the aryl-hydrocarbon-nuclear-translocator (Arnt)-defective mutant BPrc1 cells indicating that 7 displays the best chemopreventive potential.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26061105     DOI: 10.4155/fmc.15.32

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  2 in total

1.  New hits as phase II enzymes inducers from a focused library with heteroatom-heteroatom and Michael-acceptor motives.

Authors:  Mauricio Cabrera; Stefani de Ovalle; Mariela Bollati-Fogolín; Fabiana Nascimento; Patrícia Corbelini; Fernanda Janarelli; Daniel Kawano; Vera Lucia Eifler-Lima; Mercedes González; Hugo Cerecetto
Journal:  Future Sci OA       Date:  2015-11-01

2.  Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells.

Authors:  Romeo Romagnoli; Filippo Prencipe; Luisa Carlota Lopez-Cara; Paola Oliva; Stefania Baraldi; Pier Giovanni Baraldi; Francisco Estévez-Sarmiento; José Quintana; Francisco Estévez
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.